MED

Medifast
$9.91
+$0.23 (+2.38%)Jul 27, 2026
4.4NeutralMoatMint rating

MoatMint rates Medifast (MED) 4.4 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 6.2 out of 10.

Key metrics

The numbers that frame MED today
Market cap
$110.19M
P/E (TTM)
-5.5
EV / FCF
-37.2
Gross margin
70.1%
EV / Sales
0.2
ROIC
-5.9%
Div yield
0%
Debt / equity
0.1
52wk Low
$9.22
52wk High
$15.20

MED stock rating

How MED scores on quality, value, growth, momentum and financial health
4.4out of 10
Neutral overallFair business, expensive priceTop 56% of ~5,000 US stocks
QualityGood6.2/10
GrowthGood7.4/10
MomentumFair2.7/10
ValueFair3.3/10
Financial HealthNeutral4.9/10

Growth

Revenue and earnings trend for MED
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about MED
Is Medifast a good buy?
Hold. Medifast has strong quality, but poor momentum makes the setup mixed. Growth looks strong, which supports the long-term business case. We think Medifast is selling at a high price.
What is the market capitalization of MED?
Medifast's market capitalization is $110.19M.
What is the P/E ratio for MED stock?
Medifast's current P/E ratio is -5.5.
What is the 52-week high for MED stock?
The 52-week high for Medifast is $15.20. The current close of $9.91 is 34.8% below that high.
What is the 52-week low for MED stock?
The 52-week low for Medifast is $9.22. The current close of $9.91 is 7.5% above that low.
Does MED stock pay dividends?
Medifast does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MED?
Medifast's Debt / Equity ratio is 0.08.